Re: HDL Functionality
|
2
|
Resverlogix Corp.
|
May 08, 2019 05:03PM
|
Re: HDL Functionality
|
2
|
Resverlogix Corp.
|
May 08, 2019 05:27PM
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 08, 2019 05:32PM
|
Re: noticed Hepalink hasn't followed the same pattern over the last month..
|
|
Resverlogix Corp.
|
May 09, 2019 10:07AM
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 09, 2019 07:09PM
|
SOMAscan And Cognition Etc
|
2
|
Resverlogix Corp.
|
May 09, 2019 08:05PM
|
FGEN /CKD Readout
|
3
|
Resverlogix Corp.
|
May 10, 2019 12:05PM
|
Re: Antibodies Against Microglial Receptors TREM2 and CD33 Head to Trials
|
6
|
Resverlogix Corp.
|
May 11, 2019 07:04AM
|
Another Indication ?
|
1
|
Resverlogix Corp.
|
May 11, 2019 10:05AM
|
Re: Another Indication ?
|
1
|
Resverlogix Corp.
|
May 11, 2019 10:55AM
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
1
|
Resverlogix Corp.
|
May 14, 2019 05:05PM
|
Lockup
|
2
|
Resverlogix Corp.
|
May 17, 2019 09:53AM
|
Re: Last hour.....
|
1
|
Resverlogix Corp.
|
May 31, 2019 03:48PM
|
Re: Last hour.....
|
4
|
Resverlogix Corp.
|
Jun 01, 2019 01:51AM
|
Re: Radio Silence
|
1
|
Resverlogix Corp.
|
Jun 03, 2019 04:27PM
|
# Of Sites
|
|
Resverlogix Corp.
|
Jun 05, 2019 03:26PM
|
Market Pricing
|
6
|
Resverlogix Corp.
|
Jun 12, 2019 04:41PM
|
ALP & Biomarker Signatures
|
5
|
Resverlogix Corp.
|
Jun 13, 2019 01:01PM
|
Yawn
|
5
|
Resverlogix Corp.
|
Jun 20, 2019 03:55PM
|
Re: Probability of Phase 3 trial success
|
2
|
Resverlogix Corp.
|
Jun 22, 2019 07:52PM
|